Biological Therapy Analysis & Statistics, March 2012 (p7)

Forticell Bioscience, Inc. (Symbol:FORBQ) SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
March 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biological Therapy
Countries : United States

Biologics Market in Brazil

$ 6 000
Industry report
March 2012
by Frost & Sullivan

This research service considers the biologics market in Brazil. It covers the market's move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, ...

Industries : Biological Therapy
Countries : Brazil

Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Fibrocell Sciences, Inc. (Fibrocell), formerly Isolagen, Inc., is an aesthetic and therapeutic development ...

Industries : Biological Therapy
Countries : United States

Bioheart, Inc. (BHRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Bioheart, Inc. (BHRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Bioheart, Inc. (Bioheart) is a biotechnology company engaged in the development and marketing of autologous cell ...

Industries : Biological Therapy
Countries : United States

Advanced Cell Technology, Inc. (ACTC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Advanced Cell Technology, Inc. (ACTC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Advanced Cell Technology, Inc. (ACT) is a publicly traded biotechnology company, specializes in ...

Industries : Biological Therapy
Countries : United States

Lonza Group Ltd (LONN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Lonza Group Ltd (LONN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Lonza Group Ltd (Lonza) is a chemical and biotechnology company engaged in offering chemical, biotech ingredients ...

Industries : Biological Therapy
Countries : Singapore

Capricor Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Capricor Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Capricor Inc.(Capricor) is a privately held pharmaceutical company. It is principally engaged in the discovery and development ...

Industries : Biological Therapy
Countries : United States

Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial ...

Industries : Biological Therapy

Global Gene Therapy Industry

$ 4 500
Industry report
February 2012
by Global Industry Analyst

This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through 2017. The report profiles 98 companies including many key ...

Industries : Biological Therapy
Countries : World

Global Tissue Engineering and Regeneration Market 2011-2015

$ 1 500
Industry report
February 2012
by Infiniti Research Limited

TechNavio's analysts forecast the Global Tissue Engineering and Regeneration market to grow at a CAGR of 8.5 percent over the period 2011-2015. One of the key factors contributing to this market growth ...

Industries : Biological Therapy
Countries : World

RNA Interference Therapy in Oncology Drug Pipeline Update 2012

$ 1 499
Company report
February 2012
by Bioseeker

Potentially any disease-causing gene, cell type or tissue can be targeted with RNAi, including those not 'druggable' with small molecules or protein-based therapies. There are today 43 companies plus partners ...

Industries : Biological Therapy

Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

$ 2 850
Industry report
February 2012
by Venture Planning Group

Highlights Comprehensive 260-page market and technological assessment.Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as : - Biochemical ...

Industries : Biological Therapy

Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

$ 3 600
Industry report
February 2012
by Industry Experts

Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular conditions; ...

Industries : Biological Therapy
Countries : World, United States, Europe

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

$ 3 500
Industry report
February 2012
by GBI Research

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017 Summary Leading business intelligence provider GBI Research has released its ...

Industries : Biological Therapy
Countries : World, United States, Europe

Isis Pharma and Biogen Idec Enter Global Collaboration on Antisense Program Targeting Spinal Muscular Atrophy - Deal Analysis from GlobalData

$ 500
Company report
January 2012
by Global Data

Isis Pharma and Biogen Idec Enter Global Collaboration on Antisense Program Targeting Spinal Muscular Atrophy - Deal Analysis from GlobalData Summary The report is an essential source of information and ...

Industries : Biological Therapy
Countries : World

U.S. Tissue Engineering Markets

$ 6 000
Industry report
January 2012
by Frost & Sullivan

The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, ...

Industries : Biological Therapy
Countries : United States

U.S. Tissue Engineering Markets

$ 6 000
Industry report
January 2012
by Frost & Sullivan

The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, ...

Industries : Biological Therapy
Countries : United States

Analysis of the Stem Cell Markets-Unlocking the New Era in Therapeutics

$ 6 000
Industry report
January 2012
by Frost & Sullivan

This research service analyses the emerging stem cell therapeutics applications by geographic regions, encompassing Europe - The United Kingdom, Germany, Sweden, Belgium, Finland, France and Spain. The ...

Industries : Biological Therapy
Countries : Europe, United Kingdom, Sweden, Spain, France, Germany, Finland, Belgium

2011 Biotechnology Research Review

$ 950
Industry report
January 2012
by BCC Research

REPORT SCOPE FOREWORD During 2011 we witnessed the segmentation of the biotechnology industry as had long been forseen, drawn farther afield from its initial drug focus into areas such as ?cleantech? and ...

Industries : Biological Therapy
Countries : World

Delving into Stem Cell Research and its Potential

$ 350
Industry report
January 2012
by Aruvian's R'search

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...

Industries : Biological Therapy
Countries : World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

$ 3 500
Industry report
December 2011
by GBI Research

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market ...

Industries : Biological Therapy
Countries : World, Australia, Brazil, Canada, Spain, Italy, Germany, Japan, India, China, France, United States, United Kingdom, Europe, Oceania, Asia, South America, North America

World Biological Therapy: Alpha-Mannosidosis - Pipeline Review, H2 2011

$ 500
Company report
December 2011
by Global Markets Direct

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) ? Pipeline Review, H2 2011 Global Industries Direct's, 'Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2011', provides ...

Industries : Biological Therapy
Countries : World

Strategic Analysis of the European Stem Cell Research Tools Market

$ 6 500
Industry report
December 2011
by Frost & Sullivan

The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, ...

Industries : Biological Therapy
Countries : Europe

International Brachytherapy S.A. (EZBG) - Financial and Strategic SWOT Analysis Review

$ 250
Company report
December 2011
by Global Data

International Brachytherapy S.A. (IBT Bebig) is a Europe-based medical device company, focusing on cancer treatment by radiation technology. The company is engaged in the design, development and distribution ...

Industries : Biological Therapy

Biological Therapy Industry: Emerging Technologies: Stem cells

$ 3 800
Industry report
November 2011
by Datamonitor

About This Report Stem cell therapies will play an increasingly important role in the underserved field of regenerative medicine, as preclinical discoveries are translated into the clinical setting and ...

Industries : Biological Therapy

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

$ 3 500
Industry report
November 2011
by GBI Research

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D Summary GBI Research, the leading business intelligence ...

Industries : Biological Therapy
Countries : United States

Pathfinder Cell Therapy, Inc. (SYMD) - Product Pipeline Analysis

$ 750
Company report
November 2011
by Global Data

Pathfinder Cell Therapy, Inc. (SYMD) - Product Pipeline Analysis Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial company principally ...

Industries : Biological Therapy
Countries : United States

BIOREPOSITORIES: OWNERSHIP & END-USERS - A GLOBAL MARKET WATCH, 2009-2015

$ 3 270
Industry report
November 2011
by Axis Research Mind

Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...

Industries : Biological Therapy
Countries : World

BIOREPOSITORIES: EQUIPMENTS & OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015

$ 4 710
Industry report
November 2011
by Axis Research Mind

Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...

Industries : Biological Therapy
Countries : World

BIOREPOSITORIES: TECHNOLOGIES & OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015

$ 4 440
Industry report
November 2011
by Axis Research Mind

Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...

Industries : Biological Therapy
Countries : World